Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ISR.ST
- Price
- -
- Stock movement up
- +- (%)
- Company name
- ISR Immune System Regulation Holding AB
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Biotechnology & Medical Research
- Market cap
- 96.61M
- Ent value
- 263.10M
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -78.16%
- 3 year return
- -26.80%
- 5 year return
- -29.78%
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
ISR.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 69.01M |
| EPS (TTM) | -3.73 |
| FCF per share (TTM) | -2.19 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -257.16M |
| Net income (TTM) | -257.16M |
| EPS (TTM) | -3.73 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 1.39M |
| Net receivables | 1.81M |
| Total current assets | 3.21M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 3.21M |
| Accounts payable | 813.00K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 166.86M |
| Total liabilities | 167.88M |
| Shareholder's equity | -164.67M |
| Net tangible assets | -164.67M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -128.29M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -151.06M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -8011.34% |
| Return on Invested Capital | 157.14% |
| Cash Return on Invested Capital | 92.31% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| ISR.ST | S&P500 | |
| Current price drop from All-time high | -90.14% | -13.20% |
| Highest price drop | -90.14% | -56.47% |
| Date of highest drop | 25 May 2023 | 9 Mar 2009 |
| Avg drop from high | -56.72% | -11.07% |
| Avg time to new high | 222 days | 12 days |
| Max time to new high | 908 days | 1805 days |
COMPANY DETAILS
Marketcap
96.61M
Marketcap category
Small-cap
Description
ISR Immune System Regulation Holding AB (publ) develops immunostimulatory drugs to treat chronic infectious diseases and cancer in Sweden. Its product pipeline includes Covid-19 vaccine, hepatitis B (HBV), human immunodeficiency virus (HIV), and oncology drugs. The company was founded in 2007 and is headquartered in Solna, Sweden.
Employees
5
Website
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found